Literature DB >> 10072006

The influence of anesthetic choice, PaCO2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts.

L G Remsen1, M A Pagel, C I McCormick, S A Fiamengo, G Sexton, E A Neuwelt.   

Abstract

UNLABELLED: Increasing the delivery of therapeutic drugs to the brain improves outcome for patients with brain tumors. Osmotic opening of the blood-brain barrier (BBB) can markedly increase drug delivery, but achieving consistent, good quality BBB disruption (BBBD) is essential. We evaluated four experiments compared with our standard isoflurane/O2 protocol to improve the quality and consistency of BBBD and drug delivery to brain tumor and normal brain in a rat model. Success of BBBD was assessed qualitatively with the large molecular weight marker Evans blue albumin and quantitatively by measuring delivery of the low molecular weight marker [3H]-methotrexate. With isoflurane/O2 anesthesia, the effects of two BBBD drugs of different osmolalities were evaluated at two different infusion rates and infusion durations. Arabinose was superior to saline (P = 0.006) in obtaining consistent Evans blue staining in 16 of 24 animals, and it significantly increased [3H]-methotrexate delivery compared with saline in the tumor (0.388 +/- 0.03 vs 0.135 +/-0.04; P = 0.0001), brain around the tumor (0.269 +/- 0.03 vs 0.035 +/- 0.03; P = 0.0001), brain distant to the tumor (0.445 +/- 0.05 vs 0.034 +/- 0.07; P = 0.001), and opposite hemisphere (0.024 +/- 0.00 vs 0.016 +/- 0.00; P = 0.0452). Forty seconds was better than 30 s (P = 0.0372) for drug delivery to the tumor. Under isoflurane/O2 anesthesia (n = 30), maintaining hypocarbia was better than hypercarbia (P = 0.025) for attaining good BBBD. A propofol/ N2O regimen was compared with the isoflurane/O2 regimen, altering blood pressure, heart rate, and PaCO2 as covariates (n = 48). Propofol/N2O was superior to isoflurane/O2 by both qualitative and quantitative measures (P < 0.0001). Neurotoxicity and neuropathology with the propofol/N2O regimen was evaluated, and none was found. These data support the use of propofol/N2O along with maintaining hypocarbia to optimize BBBD in animals with tumors. IMPLICATIONS: Propofol/N2O anesthesia may be better than isoflurane/O2 for optimizing osmotic blood-brain barrier disruption for delivery of chemotherapeutic drugs to brain tumor and normal brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072006     DOI: 10.1097/00000539-199903000-00018

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  20 in total

Review 1.  Intra-arterial chemotherapy for malignant gliomas: a critical analysis.

Authors:  J-K Burkhardt; H A Riina; B J Shin; J A Moliterno; C P Hofstetter; J A Boockvar
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

Review 2.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  Recent advances in blood-brain barrier disruption as a CNS delivery strategy.

Authors:  Marc-André Bellavance; Marie Blanchette; David Fortin
Journal:  AAPS J       Date:  2008-03-18       Impact factor: 4.009

4.  Hyperintense signal abnormality in subarachnoid spaces and basal cisterns on MR images of children anesthetized with propofol: new fluid-attenuated inversion recovery finding.

Authors:  C G Filippi; A M Ulug; D Lin; L A Heier; R D Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

5.  Paradoxical increase in the bispectral index during deep anesthesia in New Zealand white rabbits.

Authors:  Alexander Romanov; Rajinder-Singh Moon; Mei Wang; Shailendra Joshi
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-01       Impact factor: 1.232

6.  Real-time hemodynamic response and mitochondrial function changes with intracarotid mannitol injection.

Authors:  Shailendra Joshi; Rajinder Singh-Moon; Mei Wang; Jeffrey N Bruce; Irving J Bigio; Avraham Mayevsky
Journal:  Brain Res       Date:  2014-01-15       Impact factor: 3.252

7.  Blood-brain barrier disruption and vascular damage induced by ultrasound bursts combined with microbubbles can be influenced by choice of anesthesia protocol.

Authors:  Nathan McDannold; Yongzhi Zhang; Natalia Vykhodtseva
Journal:  Ultrasound Med Biol       Date:  2011-06-08       Impact factor: 2.998

8.  The feasibility of real-time in vivo optical detection of blood-brain barrier disruption with indocyanine green.

Authors:  Aysegul Ergin; Mei Wang; Jane Y Zhang; Jeffrey N Bruce; Robert L Fine; Irving J Bigio; Shailendra Joshi
Journal:  J Neurooncol       Date:  2011-10-01       Impact factor: 4.130

9.  Rat model of blood-brain barrier disruption to allow targeted neurovascular therapeutics.

Authors:  Jacob A Martin; Alexander S Maris; Moneeb Ehtesham; Robert J Singer
Journal:  J Vis Exp       Date:  2012-11-30       Impact factor: 1.355

10.  Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke.

Authors:  Hélène N David; Benoît Haelewyn; Jean-Jacques Risso; Nathalie Colloc'h; Jacques H Abraini
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.